Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Technical Analyst: The Outlook for Oil Is Bleak

Technical analyst Clive Maund explains why he is bearish on oil and what could alter that outlook. A commodity that will certainly not do well in a recession/depression is oil. So much capacity has been brought on-stream in recent years, particularly in the ...

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...

Oil Price Action – Like a Coiled Spring Already?

Trading slightly above the $50 mark, crude oil hasn’t made a decisive move either way so far. Yesterday’s bullish session has brought us new clues. Let’s dive and examine the strength of the evolving oil move higher. We&Close...

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...

Zscaler Shares Trade Up 25% After Landing US DIU Secure Cloud Contract

Shares of Zscaler Inc. set a new 52-week high price after the company reported that it was selected by the U.S. DoD's Defense Innovation Unit for a secure cloud management project. Cloud-based security company Zscaler Inc. (ZS:NASDAQ) today announced that "the ...

Curis' Shares Take Off as FDA Clears IND Application for Monoclonal Anti-VISTA Antibody

Curis Inc. shares are up more than 130% and established a new 52-week high price after reporting that the FDA cleared the company's IND Application for CI-8993, its monoclonal anti-VISTA antibody. Biotechnology company Curis Inc. (CRIS:NASDAQ) , which concentrates...

Biopharma Launches Trial Testing Nitric Oxide as COVID-19 Treatment

The design, timeline and takeaways of Beyond Air's study are presented in a ROTH Capital Partners report. In a June 16 research note, ROTH Capital Partners analyst Scott Henry reported that Beyond Air Inc. (XAIR:NASDAQ) enrolled the first patient in its U.S. clin...

MXR seeking sedimentary copper in Colombia

West of Glen Canyon, Utah, a 90-million-year-old secret is hidden beneath the dry, desolate landscape. What is now one of the largest sand-dune deserts in the world, was once the middle of a vast inland ocean. Plying the waters of the Western Inland Seaway , a human transpo...

What’s with all the weird weather?

In January 2018, something strange happened in the Sahara Desert: it snowed . The Algerian town of Ain Sefra, named the “Gateway to the Sahara”, reportedly received up to an inch, barely enough to get the average North American out of bed early to scra...
1 2